Search research articles
Contact Us
Filters
Showing results (41-50 of 326) with videos related to
Page
of 33
Sort By:
Lancet (London, England)
|
November 30, 2018
Chronic hepatitis B virus infection
Wai-Kay Seto, Ying-Ru Lo, Jean-Michel Pawlotsky, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
May 3, 2018
An update on the toxicological considerations for protease inhibitors used for hepatitis C infection
Lung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Annals of Hematology
|
June 28, 2018
Risk of viral reactivation in patients with occult hepatitis B virus infection during ruxolitinib treatment
Harinder Gill, Garret M K Leung, Wai-Kay Seto, et al.
Expert Opinion on Emerging Drugs
|
May 5, 2022
Assessing the developing pharmacotherapeutic landscape in hepatitis B treatment: a spotlight on drugs in phase II clinical trials
Rex Wan-Hin Hui, Lung Yi Mak, Wai-Kay Seto, et al.
Clinical and Molecular Hepatology
|
February 17, 2022
RNA interference as a novel treatment strategy for chronic hepatitis B infection
Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, et al.
Expert Review of Gastroenterology & Hepatology
|
January 23, 2016
Hepatitis B: treatment choice and monitoring for response and resistance
Sze-Hang Kevin Liu, Wai-Kay Seto, Ching-Lung Lai, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
December 7, 2024
Investigational RNA Interference Agents for Hepatitis B
Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, et al.
The Lancet. Global Health
|
May 13, 2022
The optimal screening strategy for chronic hepatitis B virus infection in China - Authors' reply
Shu Su, William Cw Wong, Jason J Ong, et al.
The American Journal of Gastroenterology
|
May 5, 2011
The Effects of IL-28B and ITPA polymorphisms on treatment of hepatitis C virus genotype 6
Wai-Kay Seto, Yasuhito Tanaka, Kevin Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2013
Reply to Liao et al
Wai-Kay Seto, Danny Ka-Ho Wong, Ching-Lung Lai, et al.
Page
of 33
Search research articles
Search
Showing results (41-50 of 326) with videos related to
Sort By:
Page
of 33
Lancet (London, England)
|
November 30, 2018
Chronic hepatitis B virus infection
Wai-Kay Seto, Ying-Ru Lo, Jean-Michel Pawlotsky, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
May 3, 2018
An update on the toxicological considerations for protease inhibitors used for hepatitis C infection
Lung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Annals of Hematology
|
June 28, 2018
Risk of viral reactivation in patients with occult hepatitis B virus infection during ruxolitinib treatment
Harinder Gill, Garret M K Leung, Wai-Kay Seto, et al.
Expert Opinion on Emerging Drugs
|
May 5, 2022
Assessing the developing pharmacotherapeutic landscape in hepatitis B treatment: a spotlight on drugs in phase II clinical trials
Rex Wan-Hin Hui, Lung Yi Mak, Wai-Kay Seto, et al.
Clinical and Molecular Hepatology
|
February 17, 2022
RNA interference as a novel treatment strategy for chronic hepatitis B infection
Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, et al.
Expert Review of Gastroenterology & Hepatology
|
January 23, 2016
Hepatitis B: treatment choice and monitoring for response and resistance
Sze-Hang Kevin Liu, Wai-Kay Seto, Ching-Lung Lai, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
December 7, 2024
Investigational RNA Interference Agents for Hepatitis B
Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, et al.
The Lancet. Global Health
|
May 13, 2022
The optimal screening strategy for chronic hepatitis B virus infection in China - Authors' reply
Shu Su, William Cw Wong, Jason J Ong, et al.
The American Journal of Gastroenterology
|
May 5, 2011
The Effects of IL-28B and ITPA polymorphisms on treatment of hepatitis C virus genotype 6
Wai-Kay Seto, Yasuhito Tanaka, Kevin Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2013
Reply to Liao et al
Wai-Kay Seto, Danny Ka-Ho Wong, Ching-Lung Lai, et al.
Page
of 33